Radiofrequency Thermal Ablation: Computer Analysis of the Size of the Thermal Injury Created by Overlapping Ablations

Size: px
Start display at page:

Download "Radiofrequency Thermal Ablation: Computer Analysis of the Size of the Thermal Injury Created by Overlapping Ablations"

Transcription

1 Gerald. odd III 1 Mark S. Frank 1,2 Manohar ribandi 1 Shailendra hopra 1 Kedar N. hintapalli 1 Received February 1, 2001; accepted after revision pril 18, epartment of Radiology, The University of Texas Health Science enter at San ntonio, 7703 Floyd url r., San ntonio, TX ddress correspondence to G.. odd. 2 Present address: epartment of Radiology, Massachusetts General Hospital, 55 Fruit St., oston, M JR 2001;177: X/00/ merican Roentgen Ray Society Radiofrequency Thermal blation: omputer nalysis of the Size of the Thermal Injury reated by Overlapping blations OJETIVE. The purpose of this study was to perform a computer analysis of the size of the thermal injury created by overlapping multiple thermal ablation spheres. MTERILS N METHOS. computer-assisted design system was used to create three-dimensional models of a spherical tumor, a spherical tissue volume consisting of the tumor plus a 1-cm tumor-free margin, and individual spherical ablations. These volumes were superimposed in real-time three-dimensional space in different geometric relationships. The effect of the size and geometric configuration of the ablation spheres was analyzed with regard to the ability to ablate the required volume of tissue (tumor plus margin) without leaving untreated areas or interstices. RESULTS. The single-ablation model showed that if a cm tumor-free margin is included around the tumor targeted for ablation, radiofrequency ablation devices producing 3-, 4-, and 5-cm ablation spheres can be used to treat 1-, 2-, and 3-cm tumors, respectively. The six-sphere model, in which six ablation spheres are placed in orthogonal planes around the tumor, showed that the largest tumor that may be treated with a 3-cm ablation device is 1.75 cm, whereas 4- and 5- cm ablation spheres can be used to treat tumors measuring 3 and 4.25 cm, respectively. The 14- sphere model showed that addition of eight more spheres to the six-sphere model increased the treatable tumor size to 3, 4.6, or 6.3 cm, depending on the diameter of the ablation sphere used. For treating larger tumors, we found a cylindrical model to be less efficient but easier to control. ONLUSION. Our computer analysis showed that the size of the composite thermal injury created by overlapping multiple thermal ablation spheres is surprisingly small relative to the number of ablations performed. These results emphasize the need for a methodic tumor ablation strategy. R adiofrequency thermal ablation has shown promise as an effective minimally invasive technique for the treatment of primary and secondary malignant hepatic tumors [1 4]. The complete tumor-kill rate for ablated tumors has been reported to be as high as 98% [5]. However, a moderate to high recurrence rate in local tumors has been documented in multiple studies [6 9]. The single most important factor affecting the local tumor recurrence rate after hepatic resection is the presence and size of a tumor-free margin of hepatic parenchyma along the resection margin. It has been clearly documented that tumor-free resection margins of less than 1 cm are directly related to increased local hepatic tumor recurrence rates and decreased overall patient survival [10, 11]. Our experience and a review of the published studies on radiofrequency ablation of hepatic tumors suggest that the high failure rate in local tumors seen with radiofrequency ablation treatment may be due to a gross underablation of the tumors and a failure to create an adequate tumor-free margin [6 9] (Fig. 1). lthough it seems intuitively logical that adding a 1-cm tumor-free margin would result in an increase in the overall ablation volume required to adequately treat a tumor, no study to date has been conducted to determine how large an ablation should be to treat tumors of various sizes or how ablations should be overlapped to treat larger tumors effectively. Therefore, we have used a computer-generated three-dimensional (3) model to analyze the size of the thermal injury created by solitary and overlapping thermal ablation spheres. The model takes into account the volume of a tumor and the creation of an adequate tumor-free margin. The software renders an easily understood 3 model that facilitates a JR:177, October

2 odd et al. systematic approach to treatment using the least number of ablations. We present the results derived from the model and its impact on thermal ablation planning. Materials and Methods computer-assisted design system (esign Pro 2000; ViaGrafix, Pryor, OK) was used to create 3 models of a spherical tumor, a spherical tissue volume consisting of the tumor plus a cmthick tumor-free margin, and individual spherical ablations. These were superimposed in real-time 3 space in different geometric relationships. We analyzed the effect of size and geometric configuration of the ablation spheres on the ability to ablate the required volume of tissue (tumor plus margin) without leaving untreated areas or interstices. The geometric configurations of the models were chosen based on the efficiency of filling a spherical space. We created models with one, six, and 14 spheres and overlapped the ablation spheres so that the size of a composite sphere was maximized and all the space within the composite sphere was encompassed by one or more of the individual spheres. We also evaluated the usefulness of creating overlapping thermal cylinders or columns. In this model, multiple spheres were overlapped along a single axis to create a thermal cylinder. Multiple cylinders were then overlapped to create adjacent rectangular columns. s with the spherical models, ablation spheres were overlapped in the most efficient manner to maximize the composite volume. Results Single-blation Model To adhere to the surgical principle of having a 1-cm tumor-free margin, the ablation of a spherical tumor requires that the tumor be completely enveloped by an ablation sphere that is of sufficient size to encompass the entire tumor as well as a cm-thick tumor-free rind. This 1-cm rind adds 2 cm to the diameter of the ablation that must be created to ablate a tumor and achieve a surgical margin (Fig. 2). The adoption of a surgical margin has considerable impact on the size of a tumor that can be treated by a single ablation. If a radiofrequency ablation device produces a 3-cm solitary ablation, then the largest tumor that should be treated with a single ablation is 1 cm. For devices producing 4- and 5-cm ablation spheres, the largest tumors that can be treated adequately would be 2 and 3 cm, respectively. Six-blation Model The six-sphere model is assembled with four spheres in the x y plane and two along the z- axis (Fig. 3). y adjusting the degree of overlap of adjacent spheres with the computer-aided design program, we found that a 23% overlap of the diameter of the spheres produced the largest composite internal sphere without gaps. If correctly positioned, the largest diameter of the inner composite sphere is equal to 1.25 times the diameter of a single sphere. For single-ablation spheres that are 3, 4, and 5 cm in diameter, the six-ablation model yields composite spheres that are 3.75, 5, and 6.25 cm in diameter, respectively. If a 1-cm surgical margin is applied to this model, the largest tumor that should be treated with a 3-cm ablation device is 1.75 cm, whereas for devices producing 4- and 5-cm ablation spheres, the largest treatable tumor size would be 3 and 4.25 cm, respectively. The limiting factor in the size of the composite ablation volume is the depth of the pits at the junction of three spheres (Fig. 4). 14-blation Model To encompass a contiguous spherical composite ablation volume greater than that achievable with the six-sphere model, eight additional spheres must be added to cover the Fig year-old man with hepatocellular carcinoma., Enhanced T scan obtained before ablation shows 2.5-cm hepatocellular carcinoma., Enhanced T scan obtained at the same level as 6 months after tumor was treated with single 3-cm ablation shows ablation area equal to size of tumor with no residual tumor detected., Resected liver specimen 6 months after ablation shows residual tumor (arrows) not revealed at T. Fig. 2. omputer representation of single-ablation model. Effective ablation must encompass tumor plus cm tumor-free margin. omputer drawing depicts tumor plus half of effective tumor-free margin (red sphere). This 360 margin adds 2 cm to overall diameter of ablation sphere, depicting ablation volume encompassing tumor and tumor-free margin. 778 JR:177, October 2001

3 Size of Thermal blations of Liver Tumors Fig. 3. omputer representation of construction of six-sphere thermal ablation model. -, Six-sphere ablation model is constructed by performing four ablations in the x y plane ( sequentially) and two along the z- axis (). Green sphere represents total volume of tissue requiring ablation (tumor plus 1-cm tumor-free margin), and red spheres represent individual thermal ablation spheres that are being overlapped. Largest composite ablation sphere is created when all spheres are overlapped by approximately 23% of diameter. Fig. 4. omputer representation of six-sphere thermal ablation model depicting overlapping ablation spheres that will create composite spherical ablation encompassing tumor and tumorfree margin., Six-sphere model shows fissures at intersection of spheres., ross-section through middle of model shows that maximum composite spherical ablation (green area) does not touch margins at midsection., Size of composite spherical ablation (green area) is limited by pits at intersection of three spheres., ut section of model shows size of tumor that can be adequately treated (yellow area), taking 1-cm tumor free margin (green area) into account. JR:177, October

4 odd et al. eight pits in the six-sphere model (a total of 14 ablations, Fig. 5). With all 14 spheres positioned to maximize inner volume, this model yields a composite spherical ablation diameter that is only 1.66 times the diameter of a single-ablation sphere. Thus, a single-ablation sphere of 3 cm in diameter would yield a composite spherical ablation diameter of 5 cm. Incorporating a 1-cm tumor-free margin into the model would limit the maximum treatable tumor diameter to 3 cm. For devices producing 4- and 5-cm ablation spheres, the corresponding composite ablation sphere diameters would be 6.6 and 8.3 cm, which could be used to treat tumors measuring 4.6 and 6.3 cm, respectively. ylindrical blation Model Recognizing that the 14-sphere model is technically impossible to execute clinically, we created a model of overlapping thermal cylinders or columns that could be used to treat larger tumors (Fig. 6). onceptually, the spheres are overlapped to create a cylinder, and the cylinders are overlapped as necessary to systematically ablate a tumor. In analyzing the overlap of adjacent spheres, we found that optimal 3 positioning reduced the configuration of the effective volume of the spheres to cubes, the sides of which are equal to 58% of the diameter of the sphere. This model, although technically easier to execute than the 14-sphere model, is much less efficient geometrically. For example, an eight-sphere model that renders a cube with two spheres along each edge yields a composite inner spherical volume with a diameter that is only 1.16 times that of each single-ablation sphere. In comparison, the sixsphere model previously described yields a composite ablation volume with a diameter that is 1.25 times that of the individual ablation sphere. reating a composite spherical ablation equal to the 14-sphere model would require a cylindrical model with 27 overlapping ablations that form a cube with three ablations on each side. Fig. 5. omputer representation of 14-sphere thermal ablation model., Six-ablation model shows untreated tissue (green areas) at each pit., Eight additional spheres (in blue) are used to cover eight pits., ross-section through middle of 14-sphere ablation model shows maximum diameter of composite spherical ablation (green area) that is 1.66 times diameter of single ablation., ut section of model shows size of tumor that can be adequately treated (yellow sphere) taking 1-cm tumor-free margin (green area) into account. iscussion Surgical resection of primary hepatocellular carcinoma and hepatic metastases from primary neoplasms, such as colorectal adenocarcinoma, has been shown to increase the survival and the disease-free period in carefully screened patients [12]. Percutaneous ablation techniques provide a valuable alternative to patients who do not meet surgical criteria for hepatic resection. These methods include intratumoral ethanol instillation, cryoablation, laser ablation, microwave ablation, and radiofrequency thermal ablation [4]. Tumor recurrence is the major cause of morbidity and mortality in patients who have undergone curative resection of hepatocellular carcinoma or of liver metastases from primary tumors, such as colorectal cancer. In the case of liver metastases from colorectal cancer, Pinson et al. [13] found that the overall tumor recurrence rate at a mean period of 13 months was 71%, with the liver being involved in 55% of affected patients. The liver 780 JR:177, October 2001

5 Size of Thermal blations of Liver Tumors Fig 6. omputer representation of cylindrical thermal ablation model., Thermal ablation cylinders are created by overlapping multiple ablation spheres by 58%., Overlapping of ablation cylinders creates rectangular ablation columns made up of individual ablation cubes., Sides of each ablation cube are equal to 0.58 times diameter of individual ablation sphere., blation cylinders are systematically overlapped to ablate large tumors. was the sole site of recurrence in 33% of patients. The exact incidence of intrahepatic tumor recurrence along the surgical resection margin is difficult to assess because it has not been widely reported in the surgical literature. Sugihara et al. [14] reported a local failure rate of 17% after surgical resection of colorectal metastases. This failure rate was caused by positive resection margins in 9% of patients and recurrence along the resection margin despite apparently adequate 1- cm tumor-free margins in 8% of patients. ozzetti et al. [15] reported a local hepatic tumor recurrence rate of 9% after surgical resection of colorectal liver metastases. Matsumata et al. [16] reported that in patients who had undergone curative resection of hepatocellular carcinoma, 21% of all the hepatic recurrences were at the site of the resected hepatic stump, approximating a local hepatic recurrence rate of 6.7%. The recurrence rate for local tumors after radiofrequency thermal ablation of primary and secondary malignant hepatic tumors varies from as low as 1.8% [5] to as high as 34 55% [6 9]. Several causes have been suggested for the less impressive results reported for thermal ablation treatment [6 9]. These include the technical difficulties in localizing the tumor and accurately placing the ablation electrode, heterogeneous thermodynamic properties of tissue in the ablation field (e.g., the cooling effects of blood vessels in close proximity), unpredictable volume and geometry of ablations achieved with specific ablation devices in the same patient and in different patients, underestimation of the size of the tumor or overestimation of the extent of thermal injury as visualized by different imaging techniques, and underestimation of the volume of ablation necessary to completely eradicate the tumors of varying sizes. When surgical excision is used to remove a primary or secondary malignant hepatic tumor, the desired tumor-free margin that is, the tissue without malignancy that surrounds the tumor and is excised with it is at least 1 cm. Surgical excision with a margin of less than 1 cm results in a higher recurrence rate for local tumors and decreased rate of survival when compared with those rates seen in excisions with margins of 1 cm or more [10, 11]. We have observed that the strategy used in thermal ablation of liver tumors does not appear to be sufficient to both ablate the tumor and provide an adequate tumor-free margin [6 9]. When a tumor-free margin is considered and the standards of surgical resection are applied to thermal ablation, the required ablation volume increases dramatically over that required to treat the tumor alone. For example, a 1-cm tumor would require an ablation diameter of 3 cm, or, conversely, the largest tumor diameter that could be effectively treated with a single 3-cm ablation is 1 cm. If the largest ablation that a treatment device can render is 3 cm and if a 1-cm margin is desired, then, assuming a spherical model, six ablations would be required to treat a tumor larger than 1 cm. To our knowledge, none of the radiofrequency ablation studies has followed the strict JR:177, October

6 odd et al. modeling that we have proposed. However, the high recurrence rates for local tumors reported in many of those studies suggest that tumors in many patients were undertreated. This interpretation of the results is also supported by the fact that local-tumor recurrence was more often seen in larger tumors than in smaller ones, conceivably because including all of the tumor plus a tumor-free margin within the ablation volume is difficult [5, 9, 17]. We believe that an appreciation of the effect of tumor margin on ablation strategy can result in a more thorough therapy and a diminished recurrence rate for local tumors. Furthermore, all radiofrequency devices do not produce spherical ablations nor do they produce ablations of equal size [18] (Fig. 7). Given this variation, it is imperative that an ablation strategy be modified for the radiofrequency device that is used. Our study has several potential limitations. Our computer models are based on perfect spheres that are perfectly placed; obviously, neither this shape nor placement is a reality in clinical practice. However, the irregularity of thermal lesions and the inevitable error in needle placement are further evidence of the need for an effective ablation strategy. Second, our ablation models are based on a sum effect, and no consideration has been given to the possibility that contiguous ablations may produce a composite ablation that exceeds simple volumetric addition. Last, we evaluated radiofrequency ablation as an isolated treatment. The size and effectiveness of individual ablations may be increased substantially by adjuvant techniques, such as chemoembolization, alcohol ablation, or temporary impairment of liver blood flow [19 21]. In conclusion, if radiofrequency ablation is going to challenge surgical resection as a viable alternative treatment for hepatic tumors, the complete tumor-kill rate achieved with radiofrequency ablation must approximate the complete excision rate achieved with hepatic resection. To accomplish this goal, physicians performing radiofrequency ablation must adhere to the surgical requirement of a tumor-free margin that is at least 1 cm thick. They must know the precise size and configuration of the thermal injury created by the ablation device being used, adhere to a strict ablation protocol, and be well versed in the 3 volume of the cumulative ablation sphere created by multiple overlapping ablations. cknowledgment We thank avid aker, our graphics artist, for his superb illustrations. References Fig. 7. Varying sizes of thermal ablation injury by different radiofrequency ablation devices. irrhotic liver of 63- year-old woman shows varying sizes and shapes of ablations (arrows) created before liver resection with three different radiofrequency ablation devices from different manufacturers. Marked variation emphasizes need for systematic ablation protocol. 1. McGahan JP, odd G III. Radiofrequency ablation of the liver: current status. JR 2001;176: Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. JR 2000;174: Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000;217: odd G III, Soulen M, Kane R, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. RadioGraphics 2000;20: urley S, Izzo F, elrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. nn Surg 1999;230: Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology 1997;205: Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided RF tissue ablation of liver metastases: long-term follow up. Radiology 1997;202: Kainumao O, sano T, oyama H, et al. ombined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 1999;46: Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214: ady, Jenkins RL, Steele G Jr, et al. Surgical margin in hepatic resection for colorectal metastases: a critical and improvable determinant of outcome. nn Surg 1998;227: Elias, avalcanti, Sabourin J, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998;24: Neeleman N, ndersson R. Repeated liver resection for recurrent liver cancer. r J Surg 1996;83: Pinson W, Wright JK, hapman W, Garrard L, lair TK, Sawyers JL. Repeat hepatic surgery for colorectal cancer metastasis to the liver. nn Surg 1996;223: Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuge T, Takayama T. Pattern of recurrence after hepatic resection for colorectal metastases. r J Surg 1993;80: ozzetti F, ignami P, Morabito, oci R, Gennari L. Patterns of failure following surgical resection of colorectal cancer liver metastases. nn Surg 1987;205: Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaka T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology 1989;9: Lencioni R, Goletti O, rmillotta N, et al. Radiofrequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8: de aere T, enys, Johns Wood, et al. Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. JR 2001;176: Goldberg SN, Kruskal J, Oliver S, louse ME, Gazelle GS. Percutaneous tumor ablation: increased coagulation by combining radiofrequency ablation and ethanol instillation in a rat breast tumor model. Radiology 2000;217: Rossi S, Garbagnati F, Lencioni R et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217: Goldberg SN, Hahn PF, Tanabe KK. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998;9: JR:177, October 2001

Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases

Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases Chin J Radiol 2005; 30: 153-158 153 Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases YI-YOU CHIOU YI-HONG CHOU JEN-HUEY CHIANG HSIN-KAI WANG CHENG-YEN CHANG Department

More information

Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms

Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms Diagn Interv Radiol 2007; 13:199 203 Turkish Society of Radiology 2007 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Risk factors for occurrence of local tumor progression after percutaneous radiofrequency

More information

Saline-Infused Bipolar Radiofrequency Ablation of High-Risk Spinal and Paraspinal Neoplasms

Saline-Infused Bipolar Radiofrequency Ablation of High-Risk Spinal and Paraspinal Neoplasms Radiofreque ncy blation of Spinal Neoplasms Radiofrequency blation Technical Innovation M E D E N T U R I L I M G I N G JR 2006; 186:S322 S326 0361 803X/06/1865 S322 merican Roentgen Ray Society Y O Xavier

More information

Radiofrequency ablation of lung tumors using a multitined expandable. electrode: impact of the electrode's array diameter on local tumor

Radiofrequency ablation of lung tumors using a multitined expandable. electrode: impact of the electrode's array diameter on local tumor 1 Radiofrequency ablation of lung tumors using a multitined expandable electrode: impact of the electrode's array diameter on local tumor progression ABSTRACT Purpose: To retrospectively investigate the

More information

US-Guided Radiofrequency Ablation of Hepatic Focal Lesions

US-Guided Radiofrequency Ablation of Hepatic Focal Lesions US-Guided Radiofrequency Ablation of Hepatic Focal Lesions Poster No.: C-2219 Congress: ECR 2011 Type: Scientific Exhibit Authors: D. Armario Bel, A. PLA, F. TERREL, X. Serres; BARCELONA/ES Keywords: Neoplasia,

More information

Evaluation of mulitprobe radiofrequency technology in a porcine model

Evaluation of mulitprobe radiofrequency technology in a porcine model HPB, 2007; 9: 363367 ORIGINAL ARTICLE Evaluation of mulitprobe radiofrequency technology in a porcine model WILLIAM W. HOPE 1, JASON M. ARRU 1, JASON Q. MCKEE 2, DENNIS VROCHIDES 2, BASSAM ASWAD 2, CAROLINE

More information

Radiofrequency Ablation of Liver Tumors

Radiofrequency Ablation of Liver Tumors Radiofrequency Ablation of Liver Tumors Michael M. Awad, Michael A. Choti Indications and Contraindications Indications Unresectable malignant tumors of the liver (e.g., hepatocellular carcinoma, colorectal

More information

Microwave ablation of liver metastases to overcome radiofrequency ablation limits

Microwave ablation of liver metastases to overcome radiofrequency ablation limits Microwave ablation of liver metastases to overcome radiofrequency ablation limits Poster No.: C-2456 Congress: ECR 2012 Type: Scientific Exhibit Authors: G. Carrafiello 1, A. M. Ierardi 1, V. Molinelli

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Cryosurgical Ablation of Primary or Metastatic Liver Tumors File Name: Origination: Last CAP Review: Next CAP Review: Last Review: cryosurgical_ablation_of_primary_or_metastatic_liver_tumors

More information

ONCOLOGY REPORTS 18: , 2007

ONCOLOGY REPORTS 18: , 2007 ONCOLOGY REPORTS 18: 1275-1279, 2007 Comparative study of the effects of percutaneous ethanol injection and radiofrequency ablation in cases treated with a straight or expandable electrode KAZUTAKA KUROKOHCHI

More information

Percutaneous Radiofrequency Thermal Ablation with Hypertonic Saline Injection: In Vivo Study in a Rabbit Liver Model

Percutaneous Radiofrequency Thermal Ablation with Hypertonic Saline Injection: In Vivo Study in a Rabbit Liver Model Percutaneous Radiofrequency Thermal Ablation with Hypertonic Saline Injection: In Vivo Study in a Rabbit Liver Model Jeong Min Lee, MD 1 Young Kon Kim, MD 2 Young Hwan Lee, MD 2 Sang Won Kim, MD 2 Chun

More information

PAPER. David A. Iannitti, MD; Damian E. Dupuy, MD; William W. Mayo-Smith, MD; Brian Murphy, MD

PAPER. David A. Iannitti, MD; Damian E. Dupuy, MD; William W. Mayo-Smith, MD; Brian Murphy, MD PAPER Hepatic Radiofrequency Ablation David A. Iannitti, MD; Damian E. Dupuy, MD; William W. Mayo-Smith, MD; Brian Murphy, MD Hypothesis: Hepatic radiofrequency ablation (RFA) is effective in treating

More information

A Comparative Experimental Study of the In-vitro Efficiency of Hypertonic Saline-Enhanced Hepatic Bipolar and Monopolar Radiofrequency Ablation

A Comparative Experimental Study of the In-vitro Efficiency of Hypertonic Saline-Enhanced Hepatic Bipolar and Monopolar Radiofrequency Ablation A Comparative Experimental Study of the In-vitro Efficiency of Hypertonic Saline-Enhanced Hepatic Bipolar and Monopolar Radiofrequency Ablation Jeong Min Lee, MD Joon Koo Han, MD Se Hyung Kim, MD Kyu Li

More information

Percutaneous Radiofrequency Ablation of Lung Malignant Tumours: Survival, disease progression and complication rates

Percutaneous Radiofrequency Ablation of Lung Malignant Tumours: Survival, disease progression and complication rates Percutaneous Radiofrequency Ablation of Lung Malignant Tumours: Survival, disease progression and complication rates Poster No.: C-2576 Congress: ECR 2012 Type: Authors: Keywords: DOI: Scientific Exhibit

More information

Contrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma

Contrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma Contrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma Zeno Sparchez 1, Pompilia Radu 1, Ofelia Anton 1, Mihai Socaciu 2, Radu Badea 1 1) 3 rd

More information

Radiofrequency Ablation of Rabbit Liver In Vivo: Effect of the Pringle Maneuver on Pathologic Changes in Liver Surrounding the Ablation Zone

Radiofrequency Ablation of Rabbit Liver In Vivo: Effect of the Pringle Maneuver on Pathologic Changes in Liver Surrounding the Ablation Zone Radiofrequency blation of Rabbit Liver In Vivo: Effect of the Pringle Maneuver on Pathologic Changes in Liver Surrounding the blation Zone Seung Kwon Kim, MD 1 Hyo K. Lim, MD 1 Jeong-ah Ryu, MD 1 Dongil

More information

Radiofrequency ablation in liver tumours

Radiofrequency ablation in liver tumours Annals of Oncology 15 (Supplement 4): iv313 iv317, 2004 doi:10.1093/annonc/mdh945 Radiofrequency ablation in liver tumours S. Benoist & B. Nordlinger Department of Digestive and Oncologic Surgery, Ambroise

More information

Postoperative recurrence in hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation

Postoperative recurrence in hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation Hepatology Research 36 (2006) 143 148 Postoperative recurrence in hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation Kaoru Iwata, Tetsuro Sohda, Shinya

More information

RF Ablation: indication, technique and imaging follow-up

RF Ablation: indication, technique and imaging follow-up RF Ablation: indication, technique and imaging follow-up Trongtum Tongdee, M.D. Radiology Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand Objective Basic knowledge

More information

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011

MANAGEMENT OF COLORECTAL METASTASES. Robert Warren, MD. The Postgraduate Course in General Surgery March 22, /22/2011 MANAGEMENT OF COLORECTAL METASTASES Robert Warren, MD The Postgraduate Course in General Surgery March 22, 2011 Local Systemic LIVER TUMORS:THERAPEUTIC OPTIONS Hepatoma Cholangio. Neuroendo. Colorectal

More information

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.

Liver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital. New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights

More information

Case Studies of Laser Ablation for Liver Tumors

Case Studies of Laser Ablation for Liver Tumors Case Studies of Laser Ablation for Liver Tumors Dr Giovan Giuseppe Di Costanzo, Head Physician, Department of Liver Pathophysiology - Cardarelli Hospital, Naples Case 1: HCC near vascular structures A

More information

New Energy Sources for Local Ablation Therapy. Jeong Kyong Lee, MD Ewha Womans University

New Energy Sources for Local Ablation Therapy. Jeong Kyong Lee, MD Ewha Womans University New Energy Sources for Local Ablation Therapy Jeong Kyong Lee, MD Ewha Womans University New Energy Sources for Local Ablation Therapy Microwave Ablation Irreversible Electroporation Cryoablation Microwave

More information

Staging & Current treatment of HCC

Staging & Current treatment of HCC Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt

More information

Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC

Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC Combination therapy of TACE and PEI, TACE and RFA, and PEI and RFA for treatment of HCC Poster No.: C-0747 Congress: ECR 2014 Type: Authors: Keywords: DOI: Educational Exhibit S. W. Jeon, J. H. Kwon, M.

More information

Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases

Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases Radiofrequency Ablation versus Microwave Ablation in HCC and Liver Metastases Thomas J. Vogl, B. Panahi, N. Nour-Eldin I D I R: Institute of Diagnostic and Interventional Radiology Goethe University Frankfurt,

More information

RFA for malignant and benign tumors is a minimally invasive

RFA for malignant and benign tumors is a minimally invasive Published September 15, 2011 as 10.3174/ajnr.A2661 CLINICAL REPORT J.H. Shin S.L. Jung J.H. Baek J.-h. Kim Rupture of Benign Thyroid Tumors after Radio- Frequency Ablation SUMMARY: Rupture of benign thyroid

More information

Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases

Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic Metastases Ping Liang 1 Baowei Dong 1 Xiaoling Yu 1 Yanrong Yang 2 Dejiang Yu 1 Li Su 1 Qiujin Xiao 1 Lin Sheng 1 Received April 1, 2003; accepted after revision May 14, 2003. Supported by a grant (30271252) from

More information

IVR TAE CT. Real-time Vertial Sonography(RVS) CT-MPR Realtime

IVR TAE CT. Real-time Vertial Sonography(RVS) CT-MPR Realtime IVR TAE CT Real-time Vertial Sonography(RVS)CT-MPRRealtime In the treatment of hepatocellular carcinoma, which often recurrents at the high rate, interventional radiology (IVR), a minimally invasive technique,

More information

Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin

Radiofrequency Ablation of Hepatocellular Carcinoma: Correlation Between Local Tumor Progression After Ablation and Ablative Margin Radiofrequency Ablation of Hepatocellular Carcinoma Hepatobiliary Imaging Original Research Takahide Nakazawa 1 Shigehiro Kokubu Akitaka Shibuya Koji Ono Masaaki Watanabe Hisashi Hidaka Takeshi Tsuchihashi

More information

Embolotherapy for Cholangiocarcinoma: 2016 Update

Embolotherapy for Cholangiocarcinoma: 2016 Update Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial

More information

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys? Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts

More information

Public Statement: Medical Policy Statement:

Public Statement: Medical Policy Statement: Medical Policy Title: Radiofrequency Ablation ARBenefits Approval: 10/26/2011 of Tumors Effective Date: 01/01/2012 Document: ARB0300 Revision Date: Code(s): 20982 Ablation, bone tumor(s), radiofrequency,

More information

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD

TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD UNIVERSITY OF PRETORIA STEVE BIKO ACADEMIC HOSPITAL SOUTH AFRICA TRANSEARTERIAL CHEMO- EMBOLIZATION FOR HEPATIC METASTASES FROM NEURO-ENDOCINE NEOPLASIA AND HEPATOMA DR SAMIA AHMAD 1 INTRODUCTION Hepatic

More information

RADIOFREQUENCY ABLATION

RADIOFREQUENCY ABLATION RADIOFREQUENCY ABLATION ELIZABETH DAVID M D FRCPC VASCULAR A ND INTERVENTIONAL RADIOLOGIST SUNNYBROOK HEALTH SCIENCES CENTRE GIST GASTROINTESTINAL STROMAL TUMORS Stromal or mesenchymal neoplasms affecting

More information

The Future is Evident. Introducing the Evident TM Microwave Ablation System

The Future is Evident. Introducing the Evident TM Microwave Ablation System The Future is Evident Introducing the Evident TM Microwave Ablation System As the world leader in energy-based therapies and surgical solutions for more than 40 years, we provide innovative technologies

More information

Advances in percutaneous ablation for hepatocellular carcinoma

Advances in percutaneous ablation for hepatocellular carcinoma Advances in percutaneous ablation for hepatocellular carcinoma P. Nahon1,2,3 1 Hepatology, Jean Verdier Hospital, APHP, Bondy, France 2 Paris 13 university, Sorbonne Paris Cité, UFRSMBH, Bobigny, France

More information

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options: HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,

More information

General summary GENERAL SUMMARY

General summary GENERAL SUMMARY General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with

More information

Microwave ablation of lung tumors

Microwave ablation of lung tumors Microwave ablation of lung tumors Poster No.: C-2490 Congress: ECR 2012 Type: Scientific Exhibit Authors: G. Carrafiello 1, A. M. Ierardi 1, E. Macchi 1, N. Lucchina 1, V. Molinelli 1, E. Duka 1, C. Pellegrino

More information

RFA of Tumors of the Lung: How and Why. Radiofrequency Ablation. Radiofrequency Ablation. RFA of pulmonary metastases. Radiofrequency Ablation of Lung

RFA of Tumors of the Lung: How and Why. Radiofrequency Ablation. Radiofrequency Ablation. RFA of pulmonary metastases. Radiofrequency Ablation of Lung RFA of Tumors of the Lung: How and Why Radiofrequency Ablation of Lung Ernest Scalzetti MD SUNY Upstate Medical University Syracuse NY FDA WARNING: Off-label use of a medical device Radiofrequency Ablation

More information

INTERNATIONAL JOURNAL OF ONCOLOGY 31: ,

INTERNATIONAL JOURNAL OF ONCOLOGY 31: , INTERNATIONAL JOURNAL OF ONCOLOGY 31: 485-491, 2007 485 Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy

More information

Thermal Ablation of Liver Tumours: How the Scenario Has Changed in the Last Decade

Thermal Ablation of Liver Tumours: How the Scenario Has Changed in the Last Decade Thermal Ablation of Liver Tumours: How the Scenario Has Changed in the Last Decade Authors: Paola Tombesi, Francesca Di Vece, Lara Bianchi, *Sergio Sartori Section of Interventional Ultrasound, St. Anna

More information

Virtually-tracked US-guided Radiofrequency Ablation(RFA) of Benign Thyroid Nodules: Preliminary Results

Virtually-tracked US-guided Radiofrequency Ablation(RFA) of Benign Thyroid Nodules: Preliminary Results Virtually-tracked US-guided Radiofrequency Ablation(RFA) of Benign Thyroid Nodules: Preliminary Results e-poster: 408 Congress: ESHNR 2013 2013 Type: Scientific Poster Presentation Topic: Head and Neck

More information

Five-year Survival following Radiofrequency Ablation of Small, Solitary, Hepatic Colorectal Metastases

Five-year Survival following Radiofrequency Ablation of Small, Solitary, Hepatic Colorectal Metastases Five-year Survival following Radiofrequency Ablation of Small, Solitary, Hepatic Colorectal Metastases Alice R. Gillams, MBChB, MRCP, FRCR, and William R. Lees, MBBS, FRCR, FRCS PURPOSE: Radiofrequency

More information

Radiofrequency Ablation of Primary or Metastatic Liver Tumors

Radiofrequency Ablation of Primary or Metastatic Liver Tumors Radiofrequency Ablation of Primary or Metastatic Liver Tumors Policy Number: 7.01.91 Last Review: 9/2018 Origination: 2/1996 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)

More information

S th US Contrast

S th US Contrast S3-1 Comparison of CEUS and CECT or CEMRI in Assessment of Tumor Vascularity and Response to Thermal Ablation in Patients with Hepatocellular Carcinoma: A Multi-centre Study in China Ming-De LU, 1 Xiao-Ling

More information

258 Korean J Radiol 5(4), December 2004

258 Korean J Radiol 5(4), December 2004 Comparison of Wet Radiofrequency Ablation with Dry Radiofrequency Ablation and Radiofrequency Ablation Using Hypertonic Saline Preinjection: Ex Vivo Bovine Liver Jeong Min Lee, MD 1, 2 Joon Koo Han, MD

More information

Damian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM

Damian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM Damian Dupuy, MD Image Guided Intervention (IGI) Studies 10:25 11:05 AM Image Guided Intervention (IGI) Studies Damian E. Dupuy, M.D., FACR Professor of Diagnostic Imaging The Warren Alpert Medical School

More information

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Liver Tumors. Prof. Dr. Ahmed El - Samongy Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma

More information

Small Hepatocellular Carcinoma: Comparison of Radio-frequency Ablation and Percutaneous Microwave Coagulation Therapy 1

Small Hepatocellular Carcinoma: Comparison of Radio-frequency Ablation and Percutaneous Microwave Coagulation Therapy 1 Vascular and Interventional Radiology Toshiya Shibata, MD Yuji Iimuro, MD Yuzo Yamamoto, MD Yoji Maetani, MD Fumie Ametani, MD Kyo Itoh, MD Junji Konishi, MD Index terms: Liver, CT, 761.1211, 761.12112,

More information

Populations Interventions Comparators Outcomes Individuals: With unresectable primary hepatocellular carcinoma amenable to locoregional therapy

Populations Interventions Comparators Outcomes Individuals: With unresectable primary hepatocellular carcinoma amenable to locoregional therapy Protocol Cryosurgical Ablation of Primary or Metastatic Liver Tumors (70175) Medical Benefit Effective Date: 07/01/10 Next Review Date: 01/19 Preauthorization No Review Dates: 02/07, 02/08, 01/09, 01/10,

More information

Percutaneous Radiofrequency Ablation of Hepatic Tumors During Temporary Venous Occlusion

Percutaneous Radiofrequency Ablation of Hepatic Tumors During Temporary Venous Occlusion T. de Baere 1 B. Bessoud 1 C. Dromain 1 M. Ducreux 2 V. Boige 2 N. Lassau 1 T. Smayra 1 B. V. Girish 1. Roche 1 D. Elias 3 Received March 21, 2001; accepted after revision July 31, 2001. 1 Département

More information

Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study

Angled Cool-Tip Electrode for Radiofrequency Ablation of Small Superficial Subcapsular Tumors in the Liver: A Feasibility Study Original Article Gastrointestinal Imaging http://dx.doi.org/10.3348/kjr.2016.17.5.742 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(5):742-749 Angled Cool-Tip Electrode for Radiofrequency Ablation

More information

Percutaneous ablation: indications, techniques and results

Percutaneous ablation: indications, techniques and results Percutaneous ablation: indications, techniques and results Giovan Giuseppe Di Costanzo Dipartimento dei Trapianti UOSC Epatologia AORN A Cardarelli - Napoli Treatment algorithm EASL, EORTC guidelines HCC

More information

Hepatocellular Carcinoma Treated with Percutaneous Radiofrequency Ablation: Evaluated with Sequential Biphasic Helical CT

Hepatocellular Carcinoma Treated with Percutaneous Radiofrequency Ablation: Evaluated with Sequential Biphasic Helical CT Chin J Radiol 2005; 30: 65-74 65 Hepatocellular Carcinoma Treated with Percutaneous Radiofrequency Ablation: Evaluated with Sequential Biphasic Helical CT CHEN-HAO WU 1 JEN-I HWANG 1,4,5 SIU-WAN HUNG 1

More information

Radiofrequency Ablation (RFA) For Lung Tumors: Seven Years Experience.

Radiofrequency Ablation (RFA) For Lung Tumors: Seven Years Experience. Radiofrequency Ablation (RFA) For Lung Tumors: Seven Years Experience. Poster No.: C-1619 Congress: ECR 2011 Type: Scientific Exhibit Authors: G. DE VENUTO 1, G. XHEPA 1, M. DE CHIARA 1, M. Mangini 2,

More information

Venous Thrombosis After Radiofrequency Ablation for Hepatocellular Carcinoma

Venous Thrombosis After Radiofrequency Ablation for Hepatocellular Carcinoma Vascular and Interventional Radiology Original Research Kim et al. Venous Thrombosis After Radiofrequency Ablation Vascular and Interventional Radiology Original Research Ah Yeong Kim 1 Hyunchul Rhim Minjung

More information

Hepatocellular Carcinoma: Diagnosis and Management

Hepatocellular Carcinoma: Diagnosis and Management Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm

More information

Effect of Vascular Occlusion on Radiofrequency Ablation of the Liver: Results in a Porcine Model

Effect of Vascular Occlusion on Radiofrequency Ablation of the Liver: Results in a Porcine Model Effect of Vascular Occlusion on Radiofrequency Ablation of the Liver: Results in a Porcine Model Steven B. Chinn 1 Fred T. Lee, Jr. 1 Gregory D. Kennedy 2 Cynthia Chinn 1 Christopher D. Johnson 1 Thomas

More information

Min Ju Kim, MD 1 Hyo K. Lim, MD 2 Dongil Choi, MD 2 Won Jae Lee, MD 2 Hyun-Chul Rhim, MD 2 Seonwoo Kim, PhD 3

Min Ju Kim, MD 1 Hyo K. Lim, MD 2 Dongil Choi, MD 2 Won Jae Lee, MD 2 Hyun-Chul Rhim, MD 2 Seonwoo Kim, PhD 3 Sonography Guided Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma: Effect of Cooperative Training on the Pretreatment Assessment of the Operation s Feasibility Min Ju Kim, MD 1 Hyo K.

More information

Microsatellite Distribution and Indication for Locoregional Therapy in Small Hepatocellular Carcinoma

Microsatellite Distribution and Indication for Locoregional Therapy in Small Hepatocellular Carcinoma 299 Microsatellite Distribution and Indication for Locoregional Therapy in Small Hepatocellular Carcinoma Atsushi Sasaki, M.D., Ph.D. Seiichiro Kai, M.D. Yukio Iwashita, M.D., Ph.D. Seitaro Hirano, M.D.

More information

Metastatic cancer of unknown primary site (CUP) accounts for

Metastatic cancer of unknown primary site (CUP) accounts for Diagn Interv Radiol 2009; 15:297 302 Turkish Society of Radiology 2009 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Radiofrequency ablation of metastases from cancer of unknown primary site Sophia Mylona,

More information

CRYOABLATION OF SOLID TUMORS

CRYOABLATION OF SOLID TUMORS Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-05 Effective Date: 06/16/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should

More information

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures No relevant

More information

Combined Percutaneous Radiofrequency Ablation and Ethanol Injection of Renal Tumours: Midterm Results

Combined Percutaneous Radiofrequency Ablation and Ethanol Injection of Renal Tumours: Midterm Results european urology 52 (2007) 777 784 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Combined Percutaneous Radiofrequency Ablation and Ethanol Injection of Renal

More information

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1

RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1 RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI Chapter 1 Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on the Use of Contrast

More information

Paolo Giorgio Arcidiacono MD FASGE

Paolo Giorgio Arcidiacono MD FASGE LOCAL ABLATIVE TREATMENT OF PANCREATIC SOLID LESIONS. WHERE ARE WE NOW? Paolo Giorgio Arcidiacono MD FASGE Pancreato-Biliary Endoscopy & Endosonography Division Pancreas Translational & Clinical Research

More information

Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication

Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication Avoidable Nerve Damage in Radiofrequency Ablation Interventional Radiology Technical Innovation Andreas Boss 1,2 Stephan Clasen 1 Markus Kuczyk 3 Aristotelis Anastasiadis 3 Diethard Schmidt 1 Claus D.

More information

Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication

Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication Avoidable Nerve Damage in Radiofrequency Ablation Interventional Radiology Technical Innovation Andreas Boss 1,2 Stephan Clasen 1 Markus Kuczyk 3 Aristotelis Anastasiadis 3 Diethard Schmidt 1 Claus D.

More information

MR Imaging-Histopathologic Correlation of Radiofrequency Thermal Ablation Lesion in a Rabbit Liver Model: Observation during Acute and Chronic Stages

MR Imaging-Histopathologic Correlation of Radiofrequency Thermal Ablation Lesion in a Rabbit Liver Model: Observation during Acute and Chronic Stages MR Imaging-Histopathologic Correlation of Radiofrequency Thermal Ablation Lesion in a Rabbit Liver Model: Observation during Acute and Chronic Stages Jong Deok Lee, MD 1, 2 Jeong Min Lee, MD 1 Sang Won

More information

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)

doi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) bs_bs_banner Hepatology Research 2016; 46: 3 9 doi: 10.1111/hepr.12542 Special Report Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) Masatoshi Kudo, Kazuomi Ueshima,

More information

Original Report. Percutaneous Radiofrequency Ablation of Hepatic Metastases for Symptomatic Relief of Neuroendocrine Syndromes

Original Report. Percutaneous Radiofrequency Ablation of Hepatic Metastases for Symptomatic Relief of Neuroendocrine Syndromes Adam R. Henn 1 Edward A. Levine 2 William McNulty 3 Ronald J. Zagoria 1 Received July 16, 2002; accepted after revision April 8, 2003. Presented at the 2002 annual meeting of the American Roentgen Ray

More information

Microwave Ablation of Hepatic Tumors Abutting the Diaphragm Is Safe and Effective

Microwave Ablation of Hepatic Tumors Abutting the Diaphragm Is Safe and Effective Vascular and Interventional Radiology Original Research Smolock et al. Microwave blation of Hepatic Tumors butting the Diaphragm Vascular and Interventional Radiology Original Research manda R. Smolock

More information

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center

Hepatobiliary Malignancies Retrospective Study at Truman Medical Center Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which

More information

There is no universal algorithm implemented. Percutaneous Ablation of Hepatocellular Carcinoma: State-of-the-Art

There is no universal algorithm implemented. Percutaneous Ablation of Hepatocellular Carcinoma: State-of-the-Art Percutaneous Ablation of Hepatocellular Carcinoma: State-of-the-Art Riccardo Lencioni, Dania Cioni, Laura Crocetti, and Carlo Bartolozzi Percutaneous ablation is considered the best treatment option for

More information

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD

Interventional Radiology in Liver Cancer. Nakarin Inmutto MD Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT

More information

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging

Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Celsion Symposium New Paradigms in HCC Staging: HKLC vs. BCLC Staging Ronnie T.P. Poon, MBBS, MS, PhD Chair Professor of Hepatobiliary and Pancreatic Surgery Chief of Hepatobiliary and Pancreatic Surgery

More information

Percutaneous cryoablation of lung tumors

Percutaneous cryoablation of lung tumors Percutaneous cryoablation of lung tumors Poster No.: C-0811 Congress: ECR 2013 Type: Authors: Keywords: DOI: Scientific Exhibit C. Pusceddu 1, L. Melis 1, G. B. Meloni 2 ; 1 Cagliari/IT, 2 Sassari/IT Lung,

More information

New Techniques for Treating Chronic Knee and Hip Pain Using Radiofrequency Ablation (RFA) James Sigler, MD Katherine Travnicek, MD

New Techniques for Treating Chronic Knee and Hip Pain Using Radiofrequency Ablation (RFA) James Sigler, MD Katherine Travnicek, MD New Techniques for Treating Chronic Knee and Hip Pain Using Radiofrequency Ablation (RFA) James Sigler, MD Katherine Travnicek, MD New Techniques Physics of RFA Knee (genicular) RFA Hip RFA Business Development

More information

Management of Colorectal Liver Metastases

Management of Colorectal Liver Metastases Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver

More information

HEPATOCELLULAR CARCInoma

HEPATOCELLULAR CARCInoma REVIEW ARTICLE Radiofrequency Ablation of Liver Tumors A Systematic Review Leanne M. Sutherland, PhD; John A. R. Williams, MBBS; Robert T. A. Padbury, PhD; David C. Gotley, MBBS; Bryant Stokes, MBBS, AM;

More information

Citation for published version (APA): Hompes, D. N. M. (2013). Advanced colorectal cancer: Exploring treatment boundaries.

Citation for published version (APA): Hompes, D. N. M. (2013). Advanced colorectal cancer: Exploring treatment boundaries. UvA-DARE (Digital Academic Repository) Advanced colorectal cancer: Exploring treatment boundaries Hompes, Daphne Link to publication Citation for published version (APA): Hompes, D. N. M. (2013). Advanced

More information

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma

Early detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S144 S148 Early Detection and Curative Treatment of Early-Stage MASATOSHI KUDO Department of Gastroenterology and Hepatology, Kinki University School of

More information

Breast Ultrasound Certification - Diagnostic Cases Score

Breast Ultrasound Certification - Diagnostic Cases Score Breast Ultrasound Certification - Diagnostic Cases Score 1. Is there a correctly identified and clearly seen lesion shown in two orthogonal projections? If "Yes", continue scoring If "Somewhat" enter -5

More information

Locoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates

Locoregional Treatments for HCC Applications in Transplant Candidates. Locoregional Treatments for HCC Applications in Transplant Candidates Locoregional Treatments for HCC Applications in Transplant Candidates Matthew Casey, MD March 31, 2016 Locoregional Treatments for HCC Applications in Transplant Candidates *No disclosures *Off-label uses

More information

Current Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005

Current Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005 Current Treatment of Colorectal Metastases Dr. Thavanathan Surgical Grand Rounds February 1, 2005 25% will have metastases at initial presentation 25-50% 50% will develop metastases later 40% of potentially

More information

Liver Cancer: Diagnosis and Treatment Options

Liver Cancer: Diagnosis and Treatment Options Liver Cancer: Diagnosis and Treatment Options Fred Poordad, MD Chief, Hepatology University Transplant Center Professor of Medicine UT Health, San Antonio VP, Academic and Clinical Affairs, Texas Liver

More information

Treatment of Hepatocellular Carcinoma. Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center

Treatment of Hepatocellular Carcinoma. Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center Treatment of Hepatocellular Carcinoma Andrew J. Muir, MD MHS Division of Gastroenterology Duke University Medical Center Epidemiology of HCC: world The 5 th most common cancer worldwide > 500, 000 new

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.

More information

Imaging post liver thermal ablation: what you need to know

Imaging post liver thermal ablation: what you need to know Imaging post liver thermal ablation: what you need to know Poster No.: C-1376 Congress: ECR 2013 Type: Educational Exhibit Authors: D. K. Filippiadis, M. Mademli, A. Mazioti, N. Oikonomopoulos, S. Argentos,

More information

Synchronous Hepatic Cryotherapy and Resection

Synchronous Hepatic Cryotherapy and Resection HPB Surgery, 2000, Vol. 11, pp. 379-382 Reprints available directly from the publisher Photocopying permitted by license only (C) 2000 OPA (Overseas Publishers Association) N.V. Published by license under

More information

RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN)

RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN) RFA-based Combination Therapy 肝病研究中心, 肝臟科 林口長庚醫院, 長庚醫學大學 (CHANG GUNG MEMORIAL HOSPITAL, LINKUO) 林成俊 (CHEN-CHUN LIN) CONTENTS Introduction RFA-based Combination Therapy Ethanol injection (PEI) Saline perfusion

More information

Radiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience

Radiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience Radiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience Seong-Hoon Park, MD 1 Seong Kuk Yoon, MD 1 Jin Han Cho, MD 1 Jong Young Oh, MD 1 Kyung Jin Nam, MD 1 Hee-Jin Kwon,

More information

RADIATION SEGMENTECTOMY. Robert J Lewandowski, MD

RADIATION SEGMENTECTOMY. Robert J Lewandowski, MD RADIATION SEGMENTECTOMY Robert J Lewandowski, MD Robert Lewandowski, M.D. Consultant/Advisory Board: Cook Medical, LLC, Arsenal, BTG International, Boston Scientific Corp., ABK Reference Unlabeled/Unapproved

More information

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the My name is Barry Feig. I am a Professor of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. I am going to talk to you today about the role for surgery in the treatment

More information

ORIGINAL ARTICLE. A Second Liver Resection Due to Recurrent Colorectal Liver Metastases. accepted as the only curative

ORIGINAL ARTICLE. A Second Liver Resection Due to Recurrent Colorectal Liver Metastases. accepted as the only curative ORIGINAL ARTICLE A Second Liver Resection Due to Recurrent Colorectal Liver Metastases Antonio Sa Cunha, MD; Christophe Laurent, MD; Alexandre Rault, MD; Philippe Couderc, MD; Eric Rullier, MD; Jean Saric,

More information

Efficacy and safety of percutaneous microwave coagulation therapy followed by 125 I seed brachytherapy for VX2 hepatic tumors in a rabbit model

Efficacy and safety of percutaneous microwave coagulation therapy followed by 125 I seed brachytherapy for VX2 hepatic tumors in a rabbit model EXPERIMENTAL AND THERAPEUTIC MEDICINE 6: 159-163, 2013 Efficacy and safety of percutaneous microwave coagulation therapy followed by I seed brachytherapy for VX2 hepatic tumors in a rabbit model DONG-SHENG

More information

Major Complications after Radio-frequency Thermal Ablation of Hepatic Tumors: Spectrum of Imaging Findings 1

Major Complications after Radio-frequency Thermal Ablation of Hepatic Tumors: Spectrum of Imaging Findings 1 EDUCATION EXHIBIT 123 Major Complications after Radio-frequency Thermal Ablation of Hepatic Tumors: Spectrum of Imaging Findings 1 ONLINE-ONLY CME See www.rsna.org/education /rg_cme.html. LEARNING OBJECTIVES

More information